Image Data Collection of Tanned Skin During Phototherapy Treatment Using a Multi-spectral Camera
NCT ID: NCT05692544
Last Updated: 2023-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2023-11-30
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After consenting subjects at least 5 close-up images will be taken from the specified anatomical areas, at different angles, using the SMART camera. Additional reference images of skin that is not exposed to the phototherapy treatment will be taken with the SMART Camera. Global image of the skin using a regular high-resolution camera is optional. The images will be collected on baseline visit, at least every 3 phototherapy treatments (approximately once a week), and at the last phototherapy treatment visit. i.e., in total of at least 11 phototherapy treatment visits. Follow-up images will be taken at 1-week and 2 weeks following the last phototherapy treatment.
Images shall be taken from any anatomical area that does not consist of any marked lesions or skin conditions. All images will be non-identifying.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study
NCT05662592
Pilot Evaluation of Smart vs HERO Broadband Light Treatment for Pigmented Skin Lesions
NCT04936919
Evaluation of Safety and Efficacy of IPL Presets for Cutaneous Lesions
NCT05630690
Safety and Efficacy of Broad Band Light In Motion Treatment
NCT03970317
Radiotherapy or Imiquimod in Complex Lentigo Maligna
NCT02394132
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Camera Handpiece- Spectral module with a monochromatic camera, optics, and an array of LEDs at 7 different wavelengths.
2. Control Unit - an electronic box that powers and controls the camera. It includes electronics and a miniature computer.
3. Touch screen monitor - With user interface to operate the system When taking a photo, a series of cross-polarized monochromatic images are taken, each at different illumination color (wavelength). In total, seven images are taken with blue (450nm), teal (490nm), lime (570nm), orange (590nm), red (660nm), IR-1 (730nm), IR-2 (860nm). The total acquisition time for the seven images is 0.1sec. The images are stored in a dedicated directory on a removable hard disk in the control unit in correlation to patient ID entered through the user interface on the laptop. The number of images that can be taken is unlimited.
The camera passed the following safety tests by certified lab:
1. Check-up Safety Testing - IEC-60601-1 tests for investigational device by external laboratories according to IEC 60601-1, IEC 60601-2-22, IEC 60825-1, and IEC 60601-1-2 standards
2. LED Hazard Evaluation UV, Visible \& NIR Test, according to IEC62471 by an external certified laboratory
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phototherapy treatment
only patients was proscribe to phototherapy treatment can participate in the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is scheduled for 30 treatments or more of phototherapy
* Subject is capable and willing to sign an informed consent
* Subject is willing to comply with study schedule
* Subject has areas of skin that do not consist any marked lesions, hairs or skin conditions and can be captured in the study
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lumenis Be Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUM-ABU-SMRT-22-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.